Skip Navigation
In This Section:
Search the Data About the Data Data Sources

National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES)

Description

The National Electronic Injury Surveillance Sustem -- Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES) is an expansion of the Consumer Product Safety Commission's (CPSC) National Electronic Injury Surveillance System (NEISS), used to monitor consumer-product related injuries. NEISS-CADES collects data on all adverse drug events (ADEs) treated in U.S. hospital emergency departments, whether or not associated with consumer products. NEISS data are collected from a nationally representative sample of U.S. hospital emergency departments; NEISS-CADES uses a subsample of those emergency departments for its data collection.

Supplier

Centers for Disease Control and Prevention and Consumer Product Safety Commission and Food and Drug Administration (CDC and CPSC and FDA)

Data Years Available

2002-present

Periodicity

Annual

Mode

Electronic transmission of abstracted data.

Selected Content

NEISS-CADES collects demographic data, diagnoses, drug data (name of medication, dose, concomitant medications), and tests and treatments performed in the emergency department.

Population covered

U.S. civilian non-institutionalized population.

Methodology

NEISS hospitals are a stratified probability sample of all U.S. hospitals that have at least 6 beds and provide 24 hour emergency department (ED) services. The NEISS-CADES data are collected at a subset of these hospitals and include very large inner-city hospitals with trauma centers, as well as large urban, suburban, rural, and children's hospitals. Trained onsite hospital coders abstract and code data for all cases of adverse drug events (ADEs) treated in the hospital ED. ADEs are defined as an injury related to the outpatient use of a drug resulting from allergic reaction, side effect, unintentional overdose or secondary effect. Intentional drug injuries (e.g., suicide attempts) and injuries resulting from alcohol, tobacco, or illicit drug use are excluded. Data are weighted to produce national estimates.

Response rate and sample size

NEISS collects data from a sample of 100 hospitals with 24 hour emergency department services. NEISS-CADES data are collected at 64 of these hospitals.

Interpretation Issues

N/A

References

Mendelsohn, AB: The National Electronic Injury Surveillance System: Cooperative Adverse Drug Events Surveillance System (NEISS-CADES). May 18, 2005. Powerpoint slides; available at: http://www.fda.gov/ohrms/dockets/ac/05/slides/2005-414351_09_mendelsohn_file/frame.htm.